Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.

International journal of hematology - 1 Aug 2021

Mahe Kristell, Couturaud Francis, Kerspern Hélène, Chauveau Aurélie, Ianotto Jean-Christophe

Abstract excerpt

In the 2016 WHO classification, hemoglobin and hematocrit thresholds for diagnosing polycythemia vera (PV) have been lowered, increasing the number of consultations for polycythemia investigations. In PV, beta-2 microglobulin (B2m) levels are reportedly increased, whereas erythropoietin (EPO) levels are usually low. Most secondary polycythemia cases (SP) are caused by tobacco use. We decided to analyze the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta 2-Microglobulin
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Disease Susceptibility

Share to Erythropoietin

Share to Janus Kinase 2

Share to Polycythemia

Share to Polycythemia Vera

Source

Identifiers

PMID: 34021850
DOI: 10.1007/s12185-021-03164-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.PMID 34021850Read ↗

Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.Semantic proximity Read ↗

Polycythemia Vera: Rapid Evidence Review.Semantic proximity Read ↗

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.Semantic proximity Read ↗

Evaluation of Hemoglobin and Serum Erythropoietin Levels in Patients with Polycythemia Vera and Secondary polycythemiaSemantic proximity Read ↗

Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.Semantic proximity Read ↗

How I treat polycythemia veraSemantic proximity Read ↗

Low-hemoglobin Polycythemia Vera: Diagnostic Criteria and Clinico-pathological CharacterizationSemantic proximity Read ↗

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosisSemantic proximity Read ↗

Machine Learning Classifier Using Blood Count Parameters and Erythropoietin to Predict JAK2 Mutations in Patients With Erythrocytosis.Semantic proximity Read ↗

Iron Deficiency and PolycythemiaSemantic proximity Read ↗

[Approach to the Patient with Polycythemia].Semantic proximity Read ↗

Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis: A retrospective case seriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.